The global hospital-acquired infection control market is on the brink of transformative growth, according to a recent report by Future Market Insights. Valued at USD 6.5 billion in 2023, the market is set to more than double over the next decade, achieving an estimated valuation of USD 12.7 billion by 2033, propelled by a robust compound annual growth rate (CAGR) of 7%.
Hospitals and Intensive Care Units (ICUs) are projected to play a pivotal role in this expansion, with revenue from these critical healthcare settings anticipated to grow at an even higher CAGR of 7.6%.
Key Drivers of Market Growth:
The substantial growth of the HAI control market is driven by a confluence of critical factors:
- Frequent Occurrence of Hospital-Acquired Infections: The ongoing prevalence of HAIs underscores the urgent need for effective infection control measures.
- Increasing Surgical Procedures: A growing number of surgical interventions necessitate stringent infection prevention protocols to ensure patient safety.
- Rising Geriatric Population and Chronic Diseases: The aging global population and the rising incidence of chronic illnesses are heightening the demand for advanced infection control practices.
- Advancements in Sterilization Equipment: Breakthroughs in sterilization technologies are enhancing the efficacy and efficiency of infection prevention systems.
- Enhanced Hygiene Awareness: Increasing public and institutional awareness about hygiene standards is fostering widespread adoption of infection control solutions.
High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!
Technological Innovations Shaping the Future:
The adoption of advanced sterilization methods, including e-beam sterilization and the resurgence of ethylene oxide sterilization, is set to revolutionize infection control practices. These innovations are not only improving the reliability of sterilization processes but also aligning with stringent regulatory standards in healthcare.
Future Market Insights highlights the critical role of innovation and heightened awareness in shaping the hospital-acquired infection control market. As global healthcare systems continue to prioritize patient safety and infection prevention, the demand for cutting-edge infection control solutions is expected to soar.
With the HAI control market poised for exponential growth, stakeholders across the healthcare ecosystem must seize this opportunity to invest in technologies and protocols that ensure safer healthcare environments.
Competitive Analysis:
The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.
Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:
- In 2021, STERIS purchased Cantel, a global provider of infection control products and services, through a U.S. subsidiary to broaden its vast array of sterilization services.
- In 2021, Sterigenics S.A.S., a Sotera Health Company subsidiary, increased its European sterilizing capacity by expanding its ethylene oxide factory in Rantigny, France. Getinge introduced the Getinge Solsus 66 steam sterilizer for hospitals as well as surgical instruments in 2020, which has a higher capacity and operational reliability than other sterilizers.
- In 2020, Sotera Health Company acquired Iotron, a prominent North American outsourced provider of E-beam sterilization services. The acquisition was intended to help the company expand its electron beam footprint and boost sales of the Sterigenics division.
Market Segments Covered in Hospital-acquired Infection Control Industry Analysis:
By Component:
- Equipment
- Sterilization Equipment
- Disinfection Equipment
- Consumables
- Disinfectants
- Sterilization Consumables
- Others (Waste Disposal, PPE)
- Services
By End-user:
- Hospitals and Intensive Care Units
- Ambulatory Surgical and Diagnostic Centers
- Other End-users
๐ค๐๐๐ ๐๐๐พ ๐ฅ๐ฌ๐จโ๐ ๐ฑ๐พ๐ ๐บ๐๐พ๐ฝ ๐ฎ๐๐๐๐๐๐ ๐ข๐๐๐พ๐๐บ๐๐พ ๐๐ ๐ง๐พ๐บ๐ ๐๐๐ผ๐บ๐๐พ ๐ฌ๐บ๐๐๐พ๐ ๐จ๐๐๐๐๐๐๐ ๐ฃ๐๐๐บ๐๐:
Surgical Sphincteroplasty Industry
Single-use Bioprocessing Probes and Sensors Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:ย ย ย ย ย ย ย ย
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries:ย sales@futuremarketinsights.com
Website:ย https://www.futuremarketinsights.com
LinkedIn|ย Twitter|ย Blogs | YouTube